Stock Price & Analysis

Based on the analysis of CHE stock, it is recommended to sell as it has reached a key resistance level and shows signs of overbought conditions.

The price prediction for CHE stock in 2025 is expected to reach $650-$708, driven by strong Q4 earnings and improving business segments. The stock is currently trading at $608.07 with a Fibonacci pivot of $597.67, indicating potential upside. Analysts maintain a Buy rating with a consensus price target of $708, supported by VITAS growth and Roto-Rooter recovery.

The S1 support level for CHE Stock is $588.48 ,The R1 resistant level for CHE Stock is $608.34.

As of the end of day on 2025-03-19, the price of CHE Stock was $604.3.

The target price for CHE Stock according to analyst rating is 708.00, with the highest price target at 708.00 and the lowest at 708.00. Analysts have a Moderate Buy rating on CHE Stock overall.

The market cap of CHE is $8.9B.

Analysis and Insights

Valuation Metrics:

Chemed Corp (CHE) currently trades at a price of $608.07 with a P/E ratio of 29.63, which is higher than the industry average, suggesting potential overvaluation. The EV/EBITDA ratio of 16.29 and P/S ratio of 4.24 further indicate a premium valuation. The P/B ratio of 8.18 is significantly high, reflecting strong market expectations for future growth.

Technical Analysis:

The stock shows a neutral RSI of 67.70, indicating no immediate overbought conditions. The MACD is positive at 12.22, suggesting upward momentum. Current price is near the Fibonacci pivot level of $597.67, with resistance at $607.73 and support at $587.62.

Analyst Sentiment:

Analysts maintain a Moderate Buy rating with an average price target of $708.00, implying a 20.01% upside. However, insider sentiment is negative, with increased share sales, including the CEO selling 2,000 shares recently.

Conclusion:

CHE appears overvalued based on high valuation metrics and negative insider sentiment. However, strong earnings and analyst targets justify some premium. Investors should exercise caution and consider waiting for a price correction or more consistent growth signals.

Chemed Corporation is engaged in purchasing, operating, and divesting subsidiaries in diverse business activities. The Company operates through two segments: VITAS and the Roto-Rooter. VITAS segment provides hospice and palliative care services to its patients through a network of physicians, registered nurses, home health aides, social workers, clergy and volunteers. It provides direct medical services to patients, as well as spiritual and emotional counseling to both patients and their families. Roto-Rooter provides plumbing, drain cleaning and water restoration services to both residential and commercial customers. Roto-Rooter segment provides plumbing, drain cleaning, excavation, water restoration and other related services to residential and commercial customers. The Roto-Rooter services are provided through a network of Company-owned branches, independent contractors and franchisees. Its Water Restoration Services involve the remediation of water and humidity after a flood.

Chemed Corporation (CHE) is expected to reach a price target of $1,200 by 2030, driven by strong earnings growth and positive analyst sentiment. The stock's current momentum, supported by a bullish MACD and average analyst target of $708, indicates sustained upward potential.

CHE has a total of 15087 employees.